|
|
||||||||||||||
|
|
|||||||||||||||
Therapeutics |
Clinical impact ratings GP/FP/Primary care






Internal medicine 





Cardiology 





Key Words: ambulatory care cardiac output (low) hotlines
| The first 150 words of the full text of this article appear below. |
METHODS
Design:
randomised controlled trial.
Allocation:
concealed.*
Blinding:
blinded (outcome adjudicators {and data analysts}
).*
Follow up period:
mean 16 months (range 727 mo).
Setting:
51 centres (public and private hospitals and ambulatory settings) in Argentina.
Patients:
1518 outpatients (mean age 65 y, 71% men) who were
18 years of age; had stable HF diagnosed
3 months previously, with no admissions in the past 2 months; and had optimal drug treatment that was not modified for
2 months before the trial. Exclusion criteria included need for >1 medical visit per month; HF related to hypertrophic cardiomyopathy, significant valvular lesion, pericarditis or pericardial tamponade, primary pulmonary hypertension or cor pulmonale, or congenital cardiac malformations; reversible cardiomyopathy; recent (
3 mo) myocardial infarction or unstable angina; recent cardiac surgery/angioplasty; planned cardiac surgery or heart transplantation; symptomatic sustained ventricular tachycardia or recent history of ventricular fibrillation; regular IV pulse therapy; recent stroke; symptomatic sick
Adrian F Hernandez, MD
Duke University, Durham, North Carolina, USA
Relevant Article
Evid. Based Med. 2006 11: 63a.
(in Glossary)
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |